Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NUDT1 | P36639 | 2/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1046312 | 0.80 | NUDT1 (0.31) | NUDT1 | |
| SCHEMBL517861 | 0.79 | NUDT1 (0.30) | NUDT1 | |
| Ethylene Glycol SCHEMBL6225016 | 0.76 | — | — | |
| SCHEMBL5915888 | 0.75 | — | — | |
| SCHEMBL6228437 | 0.75 | — | — | |
| SCHEMBL4652216 | 0.75 | NUDT1 (0.33) | NUDT1 | |
| SCHEMBL6225027 | 0.73 | — | — | |
| SCHEMBL11662625 | 0.71 | — | — | |
| SCHEMBL818866 | 0.71 | — | — | |
| SCHEMBL27734631 | 0.70 | MEN1 (0.30) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-9309893-A | — | — | None | — | — | JP | disclosed |
| US-20050009967-A1 | Phosphite stabilizers and methods to preparation and polymer composition thereof | CROMPTON CORPORATION | 2005-01-13 | — | — | US | disclosed |
| WO-2004111158-A1 | PHOSPHITE STABILIZERS AND METHODS TO PREPARATION AND POLYMER COMPOSITION THEREOF | CHEMTURA CORPORATION (US) | 2004-12-23 | — | — | WO | disclosed |
| EP-0940407-B1 | Cyclic bis-phosphites | GEN ELECTRIC (US) | 2003-12-03 | — | — | EP | disclosed |
| EP-0785209-B1 | Neo diol phosphite esters and polymeric compositions thereof | GEN ELECTRIC (US) | 2003-05-07 | — | — | EP | disclosed |
| EP-0940407-A1 | Cyclic bis-phosphites | GENERAL ELECTRIC COMPANY (US) | 1999-09-08 | — | — | EP | disclosed |
| JP-H09309893-A | NEODIOL PHOSPHITE ESTER AND ITS POLYMER COMPOSITION | GENERAL ELECTRIC CO <GE> | 1997-12-02 | — | — | JP | disclosed |
| EP-0785209-A1 | Neo diol phosphite esters and polymeric compositions thereof | GENERAL ELECTRIC COMPANY (US) | 1997-07-23 | — | — | EP | disclosed |
| US-5618866-A | Neo diol phosphite esters and polymeric compositions thereof | GENERAL ELECTRIC COMPANY (US) | 1997-04-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050009967-A1 | Phosphite stabilizers and methods to preparation and polymer composition thereof | PHOSPHO1, OR51E2, CDIPT | NUDT1 312/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.